ArticleScientific reports2022

Biomarker LEPRE1 induces pelitinib-specific drug responsiveness by regulating ABCG2 expression and tumor transition states in human leukemia and lung cancer.

A-Ram Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.